Archimedes, a San Francisco-based healthcare modeling company and subsidiary of Kaiser Permanente, was sold this week to Evidera, a Bethesda, Md.-based provider of evidence-based software for healthcare providers.
The amount of the transaction was not disclosed.
Archimedes’ predictive modeling clinical decision support tool, IndiGO allows providers to better understand a patient’s current risk profile and the reduction in risk provided by specific interventions. It makes use of 30 patient-specific variables.
Evidera, which is owned by Symphony Technology Group (STG), a private equity firm, will integrate this tool in conjunction with its simulation offerings and with its analytics and health economics software and data interface capabilities. It plans to add additional disease areas to the Archimedes Model.
“The acquisition of Archimedes by STG and Evidera opens up an exciting new chapter in the use of quantitative methods to improve the quality and control the cost of healthcare,” David Eddy, M.D. Ph.D., Co-Founder of Archimedes, said in a statement. “The work we have done over the last 20 years to build and validate our models will be beautifully complemented by Evidera’s skills, experience, current products and services, and commercial strengths. The combination raises healthcare modeling and analytics to an entirely new level.”